ライフサイエンスコーパス: p

1 p-Methoxybenzyl group deprotection of 16, phosphitylatio

2 s was equally prevalent (90.2% versus 89.0%, p = 0.738).

3 s higher with PN vs. Controls (12.5% vs. 0%, p = 0.024).

4 tate changes, 77.1 +/- 7.3 vs 71.2 +/- 11.0, p = 0.043 FDR-corrected) than beginner chess players.

5 tate numbers, 75.8 +/- 7.9 vs 68.8 +/- 12.0, p = 0.043 FDR-corrected) and changes from one meta-state

6 8; p < 0.001) for NHB, 2.8 (95% CI 2.7, 3.0; p < 0.001) for Hispanic, 2.2 (95% CI 1.8, 2.6; p < 0.001

7 -0.1917 (not significantly different from 0; p=0.2968) in the entire group, -0.0357+/-0.2204 (not sig

8 -0.2204 (not significantly different from 0; p=0.351 in the patients who had received <15 doses (n=34

9 -0.1332 (not significantly different from 0; p=0.655) in those who had received >=15 doses (n=20).

10 ment by time interaction (F((8,245)) = 2.02, p = 0.04), suggesting a prolongation of the antidepressa

11 to young children (OR:2.71, 95%CI 1.51-5.02, p<0.001), and among asymptomatic controls with presence

12 sis predicted lower FAAH (F(1,26.95) = 6.03, p = .021, Cohen's f = 0.27, medium effect).

13 g behavior (d = -0.17; 95% CI: -0.30, -0.04; p = 0.012).

14 , 1.092; p = 0.059] and 1.008 [0.966, 1.052; p = 0.702], respectively).

15 027, 1.107; p = 0.001], 1.044 [1.007, 1.082; p = 0.017], and 1.190 [1.146, 1.235; p < 0.001], respect

16 ated with NO2 and PM10 (1.044 [0.998, 1.092; p = 0.059] and 1.008 [0.966, 1.052; p = 0.702], respecti

17 significantly more patients (72.7% vs 23.1% p = 0.04) despite overall larger baseline defect size (3

18 sttraumatic stress disorder (52.4% vs 37.1%; p = 0.03).

19 atoduodenectomies compared < 60 (4% vs. 10%, p = 0.046).

20 8% (95% confidence interval [CI]: 6% to 10%; p < 0.001), soluble ST2 by 4% (95% CI: 1% to 7%; p = 0.0

21 for NO2, PM10, and SO2 (1.066 [1.027, 1.107; p = 0.001], 1.044 [1.007, 1.082; p = 0.017], and 1.190 [

22 (n=207; hazard ratio 0.89, 95% CI 0.71-1.11; p=0.30).

23 dient (16 mm Hg [sd, 6] vs 39 mm Hg SD, 11]; p < 0.001) and in the relationship of jugular venous bul

24 ed by type 2 MI (34.2%) and type 1 MI (12%) (p < 0.001).

25 ron (95% confidence interval [CI] = 17-127%, p = 0.004) than immunopattern III lesions, and 30% more

26 (>0.11 ml(-1) OR 3.067, 95% CI 1.825-5.128, p < 0.001).

27 for overall survival (Relative Risk: 2.129, p < 0.0001) and recurrence-free survival (Relative Risk:

28 evalence ratio [PR] 1.08 [95% CI 1.02-1.14], p=0.032).

29 with ipilimumab (HR 0.87 [95% CI 0.66-1.14]; p=0.31).

30 higher in Cit-B12 than placebo (33% vs 15%, p = 0.04).

31 (26% vs. 16.3% in patients without COVID-19, p=0.0197; relative risk=1.6).

32 lation (odds ratio, 3.25; 95% CI, 2.52-4.19; p < 0.01) and vasopressors use (odds ratio, 1.42; 95% CI

33 (32.7 +/- 19.5 mm(2) vs 21.5 +/- 10.7 mm(2), p = 0.11).

34 ay mortality by -1.6% (95% CI, -3.4 to -0.2, p = 0.039) and 90-day mortality by -2.3% (95% CI, -4.3 t

35 59.35; p < 0.001), putamen (F(1,59) = 87.20; p < 0.001) and hippocampus (F(1,59) = 14.49; p < 0.001)

36 west of 7% (20/284) after refresher in 2017 (p = 0.001), increased again to an average of 9.6% (240/2

37 pothetical (d = -0.32; 95% CI: -0.44, -0.21; p < 0.001) and actual consumption and purchasing behavio

38 ovirus infection (OR:4.23; 95%CI 1.16-14.22, p<0.05).

39 p = 0.02) and less often asthma (8% vs 23%; p < 0.01).

40 1.082; p = 0.017], and 1.190 [1.146, 1.235; p < 0.001], respectively) when highest and lowest pollut

41 and higher emotional exhaustion (r = 0.246; p = 0.0007).

42 (HR [versus placebo] 0.75, 95% CI 0.44-1.26, p=0.27), especially if they had an IFNgamma signature lo

43 ly associated with SO2 (1.207 [1.154, 1.262; p < 0.001]) but not significantly associated with NO2 an

44 lung tissue and gas recruitment (R = 0.266, p = 0.008, R = 0.357, p = 0.002, respectively).

45 Specialist palliative care (37% versus 27%, p = 0.002) and AD inclusion in hospital files (10% versu

46 primary diagnosis of pneumonia (41% vs 28%; p = 0.02) and less often asthma (8% vs 23%; p < 0.01).

47 urrence-free survival (Relative Risk: 1.299, p < 0.0001) in patients with HCC.

48 inclusion in hospital files (10% versus 3%, p < 0.001) were more likely in the intervention group.

49 pco surgeons by 20.9% (95% CI, 18.5 to 23.3, p<0.001) with a relative decrease in 30-day mortality by

50 16.3 (95% confidence interval: 4.1 to 65.3; p < 0.0001).

51 djusted analyses (HR 0.98, 95% CI 0.73-1.31, p=0.89).

52 , 95% confidence interval [CI] 10.10-106.31, p = 0.02) with increased risk of macrosomia (odds ratio

53 e IFG specific to the VAN (F(1,57) = 10.311, p = .002).

54 34.85; p < 0.001), caudate (F(1,59) = 59.35; p < 0.001), putamen (F(1,59) = 87.20; p < 0.001) and hip

55 ecruitment (R = 0.266, p = 0.008, R = 0.357, p = 0.002, respectively).

56 ose without hydrosalpinx (95% CI: 1.02-4.36, p = 0.042).

57 B than in Group A (128.68cm3 vs. 189.37cm3; p<0.05).

58 cle number (MD 3.79%; 95% CI -9.81%, 17.39%; p = 0.585), and apolipoprotein A-1 (MD -1.83%; 95% CI -5

59 wild-type, 0.60 +/- 0.17 ms, n = 21 Kv3.3KO, p = 0.0001).

60 LFT elevations occurred in 10% vs. 4% (p=0.28), and SCr elevations occurred in 20% vs. 6% (p=0.

61 sk of subsequent admissions (72.6% vs 86.4%, p < 0.001) than those with NOM, with hazard ratio (HR) 0

62 ay mortality by -2.3% (95% CI, -4.3 to -0.4, p = 0.018).

63 aring 4+ ACEs with no ACEs was 2.0 (1.7-2.4, p < 0.001).

64 sk of death (HR, 1.134; 95% CI, 0.894-1.438; p = 0.301) as non-traumatic AKI-RRT patients.

65 ss often than younger children (29% vs. 48%; p=0.01) or adolescents (29% vs. 60%; p<0.0001).

66 p < 0.001) and hippocampus (F(1,59) = 14.49; p < 0.001) volumes.

67 yfunctionality score in group 1 vs group 4b, p<0.01).

68 1) and decreased in 40-64 years (78.0-73.5%, p = 0.001) during study period.

69 those who remained negative (21.8% vs 8.5%, p=0.01; OR 3.0, 95%CI 1.31-6.87).

70 assessment (89.45 [19.32] vs 110.10 [19.54]; p < 0.01).

71 rtemisinin-piperaquine (eight [1.5%] of 543; p=0.012).

72 LG co-contraction (affected side, r = 0.557, p = 0.020; contralateral side, r = 0.627, p = 0.007) and

73 rotein A-1 (MD -1.83%; 95% CI -5.23%, 1.56%; p = 0.290).

74 zard ratio (HR), 0.473; 95% CI, 0.392-0.571; p < 0.001), but similar rates of ESKD (HR, 1.166; 95% CI

75 , and SCr elevations occurred in 20% vs. 6% (p=0.06) of patients with SRI versus those without, respe

76 p = 0.34) or major bleeding (3.6% vs. 1.6%, p = 0.18).

77 CU at the time of diagnosis (21.0% vs. 8.6%, p = 0.024).

78 ican ancestry than controls (68.1% vs 58.6%; p = 5 x 10(-6)).

79 ide of collagen III by 3% (95% CI: 0% to 6%; p = 0.04) and increased carboxyl-terminal telopeptide of

80 n (Penetration Aspiration Scale score >= 6) (p = 0.016; odds ratio = 2.17; 95% CI 1.14-4.13) and with

81 < 0.001) for Hispanic, 2.2 (95% CI 1.8, 2.6; p < 0.001) for NHAIAN, and 1.6 (95% CI 1.4, 1.7; p < 0.0

82 s. 48%; p=0.01) or adolescents (29% vs. 60%; p<0.0001).

83 7, p = 0.020; contralateral side, r = 0.627, p = 0.007) and the Oswestry disability index scores in L

84 tes of ESKD (HR, 1.166; 95% CI, 0.829-1.638; p = 0.377) and short-term risk of death (HR, 1.134; 95%

85 ing periplaque white matter (95% CI = 3-64%, p = 0.03).

86 of lower personal accomplishment (r = -1.64; p = 0.0255) and higher emotional exhaustion (r = 0.246;

87 CVR = 0.22 [95% CI, 0.06 to 0.39], z = 2.67; p = .008).

88 same homozygous frameshift variant c.676dup (p.Trp226LeufsTer4) in M1AP, encoding meiosis 1 associate

89 (HR [versus placebo] 0.49, 95% CI 0.35-0.68, p<0.0001).

90 those receiving RACD only (0.26 [0.10-0.68], p=0.006).

91 hose without antibodies (93.4% versus 78.7%, p < 0.001), whereas taste loss was equally prevalent (90

92 0.001), soluble ST2 by 4% (95% CI: 1% to 7%; p = 0.002), and N-terminal propeptide of collagen III by

93 0.001) for NHAIAN, and 1.6 (95% CI 1.4, 1.7; p < 0.001) for NHAP populations.

94 0.61; 95% confidence interval: 0.53 to 0.71; p < 0.001).

95 ride level (MD -1.51%; 95% CI -3.75%, 0.74%; p = 0.189), very-low-density lipoprotein particle number

96 ter duration of illness (F(1,26.95) = 13.78, p = .001; Cohen's f = 0.39, medium to large effect) and

97 ncreased in patients > 65 years (11.7-17.8%, p < 0.001) and decreased in 40-64 years (78.0-73.5%, p =

98 of collagen type I by 4% (95% CI: 1% to 8%; p = 0.02) compared with valsartan alone, consistently in

99 rates of intracerebral hemorrhage (6% vs 8%; p = 0.35) did not differ.

100 s relative to NHW were 3.6 (95% CI 3.5, 3.8; p < 0.001) for NHB, 2.8 (95% CI 2.7, 3.0; p < 0.001) for

101 han in those that did not (0.48 [0.16-0.80], p=0.002), and lower in clusters that received rfMDA plus

102 rs use (odds ratio, 1.42; 95% CI, 1.10-1.83; p < 0.01) were independently associated with day 30 mort

103 hs [2.6-2.9]; HR 0.696 [95% CI 0.573-0.845]; p=0.0002).

104 and reduction of thalamus (F(1,59) = 34.85; p < 0.001), caudate (F(1,59) = 59.35; p < 0.001), putame

105 less than in Europeans (ROC AUC 0.84 v 0.87, p < 0.0001).

106 [IQR 0-40%], 44% [31-70%] and 70% [50-88%], p<0.001).

107 0.77; 95% confidence interval: 0.68 to 0.88; p < 0.001) and all-cause-mortality (7.6% vs. 9.7%; adjus

108 group (hazard ratio 0.71 [95% CI 0.57-0.88], p=0.0016).

109 ncidence rate ratio 0.52 [95% CI 0.16-0.88], p=0.009), lower in clusters receiving RAVC than in those

110 mia (odds ratio [OR] 1.38, 95% CI 1.01-1.89, p = 0.04) versus neonates of insulin-treated mothers.

111 ment of lateral ventricles (F(1,59) = 48.89; p < 0.001) and reduction of thalamus (F(1,59) = 34.85; p

112 clinically relevant bleeding (4.8% vs. 2.9%, p = 0.34) or major bleeding (3.6% vs. 1.6%, p = 0.18).

113 354 [6.6%]) than in adults (66/2297 [2.9%]) (p<0.001).

114 0.86; 95% confidence interval: 0.81 to 0.92; p < 0.001), with no significant interaction with treatme

115 year-olds (respective aRRs 1.79, 2.33, 1.92; p-values <= 0.002).

116 than the median (HR 0.88 [95% CI 0.40-1.93], p=0.74).

117 ar sexual IPV (AOR: 0.73; 95% CI: 0.56-0.94, p = 0.014), and no intervention reduced perpetration of

118 emotional, salient stimuli (F(1,125) = 4.94, p = .028) and greater activity in the portion of the IFG

119 cholesterol (OR = 0.88; 95% CI = 0.81-0.95; p = 0.002) were inversely associated with ICH risk, no s

120 tients (odds ratio, 2.35; 95% CI, 1.87-2.96; p < 0.0001) were analyzed.

121 2; 95% confidence interval [CI] = 0.85-0.99; p = 0.03) and LDL cholesterol (OR = 0.88; 95% CI = 0.81-

122 nset (RR per year 0.983; 95% CI 0.968-0.998; p = 0.002 for trend).

123 r charge transfer complex formation and as a p-dopant in organic electronic materials.

124 ents had lower levels of GABA in dorsal ACC (p = .03), and the subgroup of patients with a schizophre

125 roteobacteria [p = 0.01] and Actinobacteria [p = 0.02]) and two families (Moraxellaceae [p < 0.001] a

126 recipients with no late boost (all adjusted p<0.05, except for the polyfunctionality score in group

127 mpared to CS with or without labor (adjusted p-value 1.57 x 10(-11) and 3.70 x 10(-13), respectively)

128 tization.See related article by Ford et al., p.

129 .See related commentary by Carpenter et al., p.

130 disease.See related article by Gonda et al., p.

131 erlipidemia, and chronic kidney disease (all p < 0.001).

132 bscale, total cholesterol and education (all p < 0.05) were the influencing factors of high BMI.

133 as all crashes or at-fault crashes only (all p > 0.05).

134 1.76-fold, and 2.34-fold, respectively (all p <= 0.02).

135 eline dissimilarities in symptom scores (all p(interaction) >0.05).

136 d with worse post-explantation survival (all p > 0.05).

137 tcomes, including age at loss of ambulation (p < 0.001).

138 total phenolic and soluble protein amounts (p < 0.05).

139 control subjects on multivariable analysis (p > .05).

140 of the drug for three weeks (p < 0.0001, and p = 0.001 for sacituzumab govitecan vs naked antibody, a

141 with ASD and ADHD diagnoses (p = 0.0006 and p = 0.002, respectively).

142 sed Stop-signal reaction time; p = 0.031 and p = 0.053 respectively).

143 d total mRNFL symmetry values (p = 0.047 and p = 0.040, respectively).

144 igh-performance back-gated n-type MoS(2) and p-type WSe(2) transistors with sub-threshold values appr

145 V complete visualization rates (p = 0.30 and p = 0.14).

146 iculties in integrating complementary n- and p-channel transistors in a common quantum dot active lay

147 ctrophysiological effects of native (WT) and p.P888L SAP97, a common polymorphism.

148 OT), which distinguishes sounds like /b/ and/p/.

149 entified 5,552 trait-variant associations at p < 5 x 10(-9), including 71 novel associations not foun

150 However, SNA, resting HR, HRV, and atrial (p = 0.03) and ventricular (p = 0.03) proarrhythmia persi

151 alculations, show that (sigma, B p)->(pai, B p) transitions accelerate the ISC process.

152 h DFT/MRCI calculations, show that (sigma, B p)->(pai, B p) transitions accelerate the ISC process.

153 oved up to month 18 in both groups (Cit-B12, p < 0.0001; controls, < 0.0001-0.03); improvement at mon

154 , we discuss the strong relationship between p and both the general factor of personality and the gen

155 ations also proved to be more bioaccessible (p < 0.05).

156 s were found for HDL and triglycerides (both p > 0.05).

157 in FAF1 in the validation cohort (c.254G>C; p.Arg85Pro).

158 tosis/necrosis and phosphorylated-cAbl (cAbl-p).

159 nts and patients with dissection, right CCA (p = 0.000), ICA (p = 0.001), ECA (p = 0.004) diameters,

160 .001), ECA (p = 0.004) diameters, total CCA (p = 0.001), ICA (p = 0.009), and ECA (p = 0.003) diamete

161 l [CI] 5-29, 49-69 versus 70-82 months, chi2 p = 0.001) and 15 fewer months of overall survival (OS;

162 -1 to 31, 92-120 versus 113-129 months, chi2 p = 0.036).

163 Adjusted odds ratios (95% CI; p-value) for infant deaths were significantly increased

164 significantly more effaced basilar cisterns (p = 0.0008).

165 were most relevant to both classifications (p <= 0.044).

166 Among the RTO compounds, p-cymene and thymol were the most abundant in packed box

167 findings compared to 33/125 (26%) controls (p = 0.248).

168 differed when compared to those of controls (p < 0.05, chi-squared test).

169 (18)F-fluorodeoxyglucose PET and CSF p-tau changes occurred later in the fourth decade of lif

170 n liver and spleen at day 5 postinfection (d p.i.), although both wild-type and DUBmut virus infectio

171 and advance increased from 109 to 160 days (p = .004).

172 Also, the fermented LFs showed decreased (p < 0.05) water absorption capacity but increased swelli

173 reviously implicated in axonal degeneration (p = 1.76 x 10(-08) with amyotrophic lateral sclerosis).

174 mors (p = 0.045), and peripheral deposition (p < 0.0001) of Lipiodol showed improved response.

175 logic complications (3/61 vs 10/53 for DHCA; p < 0.05) but not complications in other organ systems.

176 hips were found with ASD and ADHD diagnoses (p = 0.0006 and p = 0.002, respectively).

177 The levels of 13 miRNAs differed (p-value < 0.05; FC > 1.5) in CD patients and controls be

178 .14)mg/dL vs. control: 0.09(-0.03,0.22)mg/dL;p = 0.797).

179 onary vascular resistance (-83 +/- 33 dynes; p = 0.07).

180 Here, we test E(p) using a variety of general biomarkers along a transec

181 right CCA (p = 0.000), ICA (p = 0.001), ECA (p = 0.004) diameters, total CCA (p = 0.001), ICA (p = 0.

182 l CCA (p = 0.001), ICA (p = 0.009), and ECA (p = 0.003) diameters were also found to be different.

183 e same model, apoB retained a robust effect (p < 0.05), whereas the estimate for LDL cholesterol was

184 included having PROs as a primary endpoint (p=0.008) and the presence of a subsequent publication on

185 0.001; <= 1 consecutive days: 0.68 d fewer, p < 0.001).

186 p = 0.010; 2 consecutive days: 0.77 d fewer, p < 0.001; <= 1 consecutive days: 0.68 d fewer, p < 0.00

187 h of stay (3 consecutive days: 0.46 d fewer, p = 0.010; 2 consecutive days: 0.77 d fewer, p < 0.001;

188 ibration curves (five-parameter logistic fit p < 0.05) by plotting the measured ratios of the MS ion

189 aried from 59 (US) to 69 mm (Nancy, France) (p < 0.001), 25.3% of patients having a diameter of < 60

190 s <=0.001) and segmental glomerulosclerosis (p-value <0.0001).

191 0.9 to 0.69 +/- 1.2 in the PKE + NPDS group (p < .001).

192 ignificant interaction with treatment group (p(interaction) = 0.17).

193 1.1 to 0.49 +/- 1.0 in the PKE + XEN group (p < .001) and from 2.93 +/- 0.9 to 0.69 +/- 1.2 in the P

194 e between the highest and lowest REA groups (p <= 0.05).

195 TE was approximately 72 h p.i., whereas 48 h p.i. was better for (177)Lu-PSMA.

196 for (177)Lu-DOTATATE was approximately 72 h p.i., whereas 48 h p.i. was better for (177)Lu-PSMA.

197 serum aldosterone were 6.8 vs. 5.5 ng/mL/h (p = 0.002) and 654 vs. 473 pg/mL (p = 0.01), respectivel

198 onary arterial pressure (-6.5 +/- 1.8 mm Hg; p = 0.005) and tended to decrease pulmonary vascular res

199 Also, homogeneous (p = 0.0006), non-sparse (p < 0.0001), rim deposition wit

200 increased from baseline by 7.8% at 24 hours (p = 0.022) and 15.0% at 48 hours (p = 0.0001) for patien

201 24 hours (p = 0.022) and 15.0% at 48 hours (p = 0.0001) for patients receiving bilateral stimulation

202 Na(+)-K(+) pump current, I(p), was measured in voltage-clamped myocytes from noninf

203 with dissection, right CCA (p = 0.000), ICA (p = 0.001), ECA (p = 0.004) diameters, total CCA (p = 0.

204 .004) diameters, total CCA (p = 0.001), ICA (p = 0.009), and ECA (p = 0.003) diameters were also foun

205 remained elevated beyond recovery from ILI (p<0.05).

206 s were significantly higher at onset of ILI (p<0.01), and remained elevated beyond recovery from ILI

207 he QT interval were significantly shorter in p.P888L-SAP97 than in WT-SAP97 mice.

208 VAT ex-vivo lipolysis was increased (p < 0.05) in P-HFHS compared to P-CD dams.

209 ficantly reduced its water absorption index (p <= 0.05).

210 nine [16%] of 55 with chikungunya infection; p<=0.0001), particularly Guillain-Barre syndrome (25 [61

211 erulitis, peritubular capillary infiltrates; p-values <=0.001) and segmental glomerulosclerosis (p-va

212 ociated with altered white matter integrity (p = 2.5x10-7) in brain images from 1,738 young healthy a

213 r Open Access versus closed access journals (p = 0.320, 95% CI - 0.015, 0.046, adjusted mean false di

214 ature on the propagation rate coefficient (k(p)), reveals the transition state barrier for polycarbon

215 Cebranopadol at a low dose of 25 ug/kg (p.o.) did not induce significant hyperactivity itself, b

216 N(theta) clusters had deteriorated with p < p(Cluster), chosen empirically to give 95% specificity b

217 tion error than the PBMC-based DNAm markers (p-value = 0.0002).

218 ) and more likely to have diabetes mellitus (p = 0.004), hypertension, hyperlipidemia, and chronic ki

219 6.3% (37/591) after the start of mentorship (p = 0.019).

220 d the three echocardiography gating methods (p > 0.05 for all).

221 rvival analysis, TNM stage (p < 0.01), mGPS (p < 0.05), NLR (p < 0.01), MUST (p <= 0.001), Low SMD (p

222 5 ng/mL/h (p = 0.002) and 654 vs. 473 pg/mL (p = 0.01), respectively.

223 icated in the Q175 Htt knock-in mouse model (p = 6.0 x 10(-8)) and in the transgenic sheep model (p =

224 x 10(-8)) and in the transgenic sheep model (p = 2.4 x 10(-88)).

225 everity groups (severe: p = 0.001, moderate: p = 0.02).

226 [p = 0.02]) and two families (Moraxellaceae [p < 0.001] and Pseudomonadaceae [p = 0.01]).

227 = 0.04) and 10 (69 +/- 4 ms to 62 +/- 3 ms; p < 0.001) miles.

228 after running 3 (65 +/- 3 ms to 62 +/- 3 ms; p = 0.04) and 10 (69 +/- 4 ms to 62 +/- 3 ms; p < 0.001)

229 le activity (all seven measured leg muscles (p >= 0.146)), soleus active muscle volume (p = 0.538; d

230 .01), mGPS (p < 0.05), NLR (p < 0.01), MUST (p <= 0.001), Low SMD (p < 0.05), SUVmax (p <= 0.001) and

231 n enrichment in chlorogenic, neochlorogenic, p-coumaric and caffeic acids was measured in most of the

232 13) for patients with grade < 3 neutropenia (p = 0.04; HR 0.44).

233 TNM stage (p < 0.01), mGPS (p < 0.05), NLR (p < 0.01), MUST (p <= 0.001), Low SMD (p < 0.05), SUVmax

234 oisomeric 3-O-camphanate esters of (+/-)-6-O-p-methoxy-benzyl-1,2:4,5-di-O-isopropylidene-myo-inosito

235 Expression of p.T224M KCNQ1 in Chinese hamster ovary cells showed near

236 ity disorder, substantive interpretations of p, and the potential clinical utility of p.

237 of p, and the potential clinical utility of p.

238 spanic White > Asian/Pacific Islander/Other; p < 0.01), with higher levels of BDE-100 and BDE-153 amo

239 402 Mg C/ha less than their rain-fed pairs (p < .0001).

240 rowing body of evidence in the use of plasma p-tau181 as a non-invasive diagnostic and prognostic too

241 In summary, plasma p-tau217 increases during early Alzheimer's disease and

242 ociated with higher levels of Porphyromonas (p < 0.05) and Prevotella.

243 1406 fmol/punch (IQR:1053, 1859) postpartum (p=0.006).

244 me (p = 0.538; d = 0.241), or aerobic power (p = 0.458; d = 0.04) during running.

245 Ultrasound depth is a significant predictor (p = 0.044) of a histologically non-benign lipoma.

246 ion gradient to cerebral perfusion pressure (p = 0.004) when comparing normoxia to hypoxia.

247 who did not cooperate during the procedure (p=0.04).

248 resence of a subsequent publication on PROs (p<0.0001).

249 ges from mucus in two phyla (Proteobacteria [p = 0.01] and Actinobacteria [p = 0.02]) and two familie

250 axellaceae [p < 0.001] and Pseudomonadaceae [p = 0.01]).

251 ecord high speed beyond 5 GHz (300 billion r.p.m.).

252 ociation to AV complete visualization rates (p = 0.30 and p = 0.14).

253 f 69.7 (21.2) and 60.7 (26.3), respectively (p = 0.029).

254 The most frequently broken motif was REST (p value = 0.0028), which has been reported as both a tum

255 locus on chromosome 8 (lead SNP rs17052966, p = 4.53 x 10(-9), odds ratio = 1.28, se = 0.04).

256 n chromosome 20, were identified: rs4809706 (p-value: 2.8 x 10(-8)), rs4810824 (p-value: 3.5 x 10(-8)

257 s4809706 (p-value: 2.8 x 10(-8)), rs4810824 (p-value: 3.5 x 10(-8)), and rs6019297 (p-value: 4.7 x 10

258 0824 (p-value: 3.5 x 10(-8)), and rs6019297 (p-value: 4.7 x 10(8)).

259 This reaction was catalyzed by the [Ru(p-cymene)Cl(2)](2) complex (3 mol %) and exhibited a bro

260 reliability and accuracy were all the same (p = 0.001).

261 95 [95% CI: 1.55 to 2.45] for the PNI score; p values <0.001 for all nutritional indexes).

262 1% of the variance in 2017 aggregate scores (p<0.0001), but we found evidence of a high degree of col

263 studies using Z-scores, modified Z'-scores, p-values and Jaccard indices.

264 to the other two MS severity groups (severe: p = 0.001, moderate: p = 0.02).

265 ratio [HR] 0.82, 95% CI 0.70-0.96; one-sided p=0.007).

266 family-wise error rate (FWER) significance (p < 1.25E-06).

267 lteplase dose was statistically significant (p = 0.018).

268 ifference was not statistically significant (p = 0.183).

269 Serum progesterone level was significantly (p = 0.026) elevated at day + 7 of transplantation, while

270 allic, and ferulic acids were significantly (p < 0.05) increased in FIR dried samples.

271 0 proteins and 55,000 phosphorylation sites (p-sites) from 125 CCLs.

272 NLR (p < 0.01), MUST (p <= 0.001), Low SMD (p < 0.05), SUVmax (p <= 0.001) and TLG (p < 0.001) were

273 Also, homogeneous (p = 0.0006), non-sparse (p < 0.0001), rim deposition within sparse tumors (p = 0.

274 On univariate survival analysis, TNM stage (p < 0.01), mGPS (p < 0.05), NLR (p < 0.01), MUST (p <= 0

275 YPLA2) depalmitoylates phosphorylated STAT3 (p-STAT3) and enables it to translocate to the nucleus.

276 ST (p <= 0.001), Low SMD (p < 0.05), SUVmax (p <= 0.001) and TLG (p < 0.001) were associated with ove

277 le in the development of the nervous system (p = 4.29 x 10(-11) with neuroticism), as well as SARM1,

278 er min higher in Peru (likelihood ratio test p<0.0001).

279 sis had higher glutamate levels in thalamus (p = .01), but Glx levels in dorsal ACC and thalamus did

280 ann cells with an antioxidant suppressed the p.N237S-induced neurodegeneration.

281 2'-bithiophen]-5-yl)thieno[3,2-b]thiophene) (p[g2T-TT]).

282 l (i.e. increased Stop-signal reaction time; p = 0.031 and p = 0.053 respectively).

283 of developing laryngeal granulation tissue (p = 0.02).

284 SMD (p < 0.05), SUVmax (p <= 0.001) and TLG (p < 0.001) were associated with overall survival.

285 TNNI3 p.Arg21Cys-related cardiomyopathy manifested a malignant

286 at there were significant increasing trends (p <= 0.05) in annual precipitation near the south coasta

287 .0001), rim deposition within sparse tumors (p = 0.045), and peripheral deposition (p < 0.0001) of Li

288 that XPRT forms a symmetric dimer with two (p)ppGpp binding sites at the dimer interface.

289 om 40% of TEVARs in the US to 72% in the UK (p < 0.001).Mean intact TAA (iTAA) diameter varied from 5

290 relation between fractional plasma volume (V(p)), a parameter derived from DCE perfusion MRI, and his

291 nd superior and total mRNFL symmetry values (p = 0.047 and p = 0.040, respectively).

292 dentified a heterozygous frameshift variant (p.Ser117HisfsTer10) in F3, the gene encoding TF, causing

293 owed that there were significant variations (p < 0.001) for all assessed quantitative traits.

294 HRV, and atrial (p = 0.03) and ventricular (p = 0.03) proarrhythmia persisted.

295 measured by ELISA (R(2)=0.67 by Marburg VN; p<0.001).

296 (p >= 0.146)), soleus active muscle volume (p = 0.538; d = 0.241), or aerobic power (p = 0.458; d =

297 3.56 +/- 1.78 weeks vs 5.87 +/- 2.20 weeks (p = 0.01) and achieved complete epithelialization in sig

298 administration of the drug for three weeks (p < 0.0001, and p = 0.001 for sacituzumab govitecan vs n

299 f >= N(theta) clusters had deteriorated with p < p(Cluster), chosen empirically to give 95% specifici

300 ntral macular thickness after 6 months, with p-values of 0.135 and 0.145, respectively.

301 SD age: 67.8 +/- 8.9 vs. 66.1 +/- 8.2 years; p < 0.001) and more likely to have diabetes mellitus (p